Allogene Therapeutics, Inc. (ALLO) Total liabilities 2019–2025
Allogene Therapeutics, Inc. (ALLO) total liabilities at each fiscal year-end, per SEC filings.
$123.4MFY2025 · since FY2019: $88.8M → $123.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $123.4M | -2.5% |
| FY2024 | $126.5M | -3.1% |
| FY2023 | $130.6M | -15.6% |
| FY2022 | $154.7M | +23.1% |
| FY2021 | $125.6M | -15.2% |
| FY2020 | $148.2M | +66.9% |
| FY2019 | $88.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice